Lung Cancer / / edited by Henry S. Park.
Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, rad...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | London, England : : IntechOpen,, 2021. |
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 online resource (224 pages) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993603194704498 |
|---|---|
| ctrlnum |
(CKB)5400000000043272 (NjHacI)995400000000043272 (EXLCZ)995400000000043272 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Lung Cancer / edited by Henry S. Park. Lung Cancer London, England : IntechOpen, 2021. 1 online resource (224 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. Lungs Cancer. Oncology. 1-78985-638-8 Park, Henry S., editor. |
| language |
English |
| format |
eBook |
| author2 |
Park, Henry S., |
| author_facet |
Park, Henry S., |
| author2_variant |
h s p hs hsp |
| author2_role |
TeilnehmendeR |
| title |
Lung Cancer / |
| spellingShingle |
Lung Cancer / |
| title_full |
Lung Cancer / edited by Henry S. Park. |
| title_fullStr |
Lung Cancer / edited by Henry S. Park. |
| title_full_unstemmed |
Lung Cancer / edited by Henry S. Park. |
| title_auth |
Lung Cancer / |
| title_alt |
Lung Cancer |
| title_new |
Lung Cancer / |
| title_sort |
lung cancer / |
| publisher |
IntechOpen, |
| publishDate |
2021 |
| physical |
1 online resource (224 pages) |
| isbn |
1-78985-638-8 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RC - Internal Medicine |
| callnumber-label |
RC280 |
| callnumber-sort |
RC 3280 L8 L864 42021 |
| illustrated |
Not Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
616 - Diseases |
| dewey-full |
616.99424 |
| dewey-sort |
3616.99424 |
| dewey-raw |
616.99424 |
| dewey-search |
616.99424 |
| work_keys_str_mv |
AT parkhenrys lungcancer |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000043272 (NjHacI)995400000000043272 (EXLCZ)995400000000043272 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Lung Cancer / |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796653218226241536 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01762nam a2200289 i 4500</leader><controlfield tag="001">993603194704498</controlfield><controlfield tag="005">20230628090930.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230628s2021 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043272</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000043272</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043272</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.L8</subfield><subfield code="b">.L864 2021</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99424</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Lung Cancer /</subfield><subfield code="c">edited by Henry S. Park.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Lung Cancer </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (224 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Lungs</subfield><subfield code="x">Cancer.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Oncology.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78985-638-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Henry S.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:12:17 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351672490004498&Force_direct=true</subfield><subfield code="Z">5351672490004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351672490004498</subfield></datafield></record></collection> |